… Cytokine storm is the major cause of death in patients with acute respiratory distress caused
by COVID-19. Because cytokine storm … options for handling the cytokine storm. The potential …

… Therefore, both MAS patients refractory to IFNγ neutralization and IFNγR-deficient patients
that develop HLH may benefit from IL-17 blocking therapies. IFNγ-independent cytokine storm …

… combination therapy. However, glucocorticoid therapy aimed at curbing the “cytokine storm”
… We thematically focus on the immunopathogenesis of COVID-19 and related CoVs, clinical …

… therapies, no specific clinical treatment exists so far and only partial information is known
about the immunopathogenesis of … Does our current knowledge of immunopathogenesis and …

… -19 is important in developing effective therapies as well as … disease-associated cytokine
storm syndrome may have mutations … of COVID-19 associated cytokine storm syndrome may, to …

… cytokine storm can also cause MOF and ultimately lead to death. Therefore, understanding
the precise role of inflammatory cytokines such as IL-6 is crucial in the immunopathogenesis …

… In this review, we provide a detailed insight into the cytokine storm phenomena as one of …
the potential therapeutic agents that could block or interfere with the cytokine storm, and …

… immune reaction in the host that called a cytokine storm, the effect is extensive tissue
destruction. This storm is protagonized by IL-6. It is produced by activated leukocytes and also acts …

… This immunopathogenesis leads to acute lung injury and acute respiratory distress syndrome
(ARDS). Targeting cytokine storm with the therapies that are already available in India with …

… COVID-19 and its immunopathogenetic basis for the severity of the … There is clinical evidence
that suggests that cytokine storm is … of pro - inflammatory cytokines - a cytokine storm that is …